Business Context and Reporting Period
Company: IDEAYA Biosciences, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: May 5, 2026
Reporting Period: First quarter ended March 31, 2026
Business Context: The filing announces the Company's financial results for the first quarter of 2026. The detailed results are contained in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover page and index for the Form 8-K. It references the announcement of financial results but does not contain the specific numerical data within the body of this document.
- Revenue: Not provided in this text.
- Profit/Loss: Not provided in this text.
- Cash Flow: Not provided in this text.
- Margins: Not provided in this text.
- Debt and Liquidity: Not provided in this text.
Note: Specific financial figures are located in Exhibit 99.1 (Press Release), which is referenced but not included in the input content.
Material Changes
The filing text does not provide specific data to compare against the prior comparable period. It only confirms that results for the quarter ended March 31, 2026, have been announced.
Guidance, Outlook, and Risks
Management Commentary: The filing states that the full text of the press release regarding the Q1 2026 results is attached as Exhibit 99.1. No specific commentary, guidance, or outlook is present in the cover document itself.
Risks and Contingencies: No specific risks or contingencies are detailed in this text. The filing includes a standard disclaimer that the information furnished in Item 2.02 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 5, 2026) for actual revenue, net loss, and cash position figures.
- Verify the specific details of the "Results of Operations" referenced in Item 2.02, as they are not embedded in the main text.
- Confirm whether the press release includes updated clinical trial timelines or regulatory milestones, which are typical for IDEAYA Biosciences.
- Check the Company's cash runway and burn rate, as these are critical metrics for a biotechnology firm not explicitly listed in this summary.